November 2015 – Page 2 – Policy & Medicine

Accountable Care Organizations Prove They are Here to Stay

2016 Physician Fee Schedule: Includes Changes on Self-Referral Rules, Biosimilars and Reimbursement, Transparency Changes for Another Day

HHS OIG Enforcement Actions on the Horizon Utilizing Open Payments, Advises Companies on Compliance

2016 Data Collection and Submittal Changes under the Open Payments System

Court Strikes Down HRSA’s 340B Orphan Drug Policy, Again

Both Houses of Congress Investigating Prescription Drug Prices

Off-label Marketing is “Dead,” Diversion Cases on the Rise

HHS OIG Issues 2016 Work Plan

Amarin Update – The Case of Many Cases

Pacira Update: A Settlement in the Works?